KRAS-G12D inhibitor shows promise in advanced pancreatic cancer: phase 1b/2 trial results
A phase 1b/2 trial published in Nature Medicine demonstrates that HRS-4642, a targeted KRAS-G12D inhibitor combined with chemotherapy, achieves encouraging…
Editor's Top Picks
NHS Maternity Crisis: Why Cultural Change Lags Behind Safety Data
A landmark NHS inquiry into maternity services in Nottingham documents 500 cases of serious or avoidable harm affecting nearly 2,500…
Submit Your Paper to GMJ
Rancid Omega-3: What the Peroxide Value Tells You
Surveys keep finding oxidised fish oil on the shelf. Peroxide value, anisidine value and TOTOX are the three numbers on…
Heat Kills Supplements: Transport, Storage and the Invisible Loss of Potency
Chemical degradation roughly doubles with every 10 °C. Hot delivery vans, sunny windowsills and steamy bathroom cabinets quietly remove potency…
What a LOT Number Really Is: Batch Traceability from Factory to Recall
No LOT number means no recall. The small code stamped on the bottle is the thread that connects your product…
Supplement Ingredient Fraud: Substitution and Dilution — How Identity Testing Catches It
The cheapest fraud in the supplement trade is a wrong or diluted ingredient. Here is how substitution works, how common…
Nobody Approves a Supplement Before It Is Sold
Supplements are foods, not medicines. No regulator anywhere approves them before sale. What that means for the buyer — and…
Glass vs Plastic: Microplastics and Your Daily Supplement
Microplastics were found in 93% of bottled waters tested. For oil-based supplements the concern is larger — and amber glass…
Why Supplements Fail Label-Claim Tests — and How to Protect Yourself
Independent laboratories keep finding supplements with less — or more — than the label declares. Here is how it happens,…
CDC Reports Sharp Rise in Hantavirus Cases Across Western United States
The CDC has reported a significant increase in hantavirus cases across western United States during 2026, activating enhanced surveillance and…

